South & Central America Parenteral Nutrition Market
The South & Central America Parenteral Nutrition Market size was valued at US$ 360.63 Mn in 2022 and is projected to reach US$ 597.42 Mn by 2030, growing at a CAGR of 6.5% during 2022 - 2030.
Report Coverage
- Nutrient Type: Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, Vitamins and Minerals
- End User: Hospitals, Clinics
US$ 360.63 Mn
Market size in 2022
US$ 597.42 Mn
Market Size by 2030
6.5%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Parenteral Nutrition Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Parenteral Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Parenteral Nutrition Market Regional Analysis
6.2 South & Central America Parenteral Nutrition Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Parenteral Nutrition Market Forecast Analysis
7. South & Central America Parenteral Nutrition Market Analysis – by Nutrient Type
7.1 Single Dose Amino Acid Solution
- 7.1.1 Overview
- 7.1.2 Single Dose Amino Acid Solution: South & Central America Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Parenteral Lipid Emulsion
- 7.2.1 Overview
- 7.2.2 Parenteral Lipid Emulsion: South & Central America Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Carbohydrates
- 7.3.1 Overview
- 7.3.2 Carbohydrates: South & Central America Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Trace Elements
- 7.4.1 Overview
- 7.4.2 Trace Elements: South & Central America Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Vitamins and Minerals
- 7.5.1 Overview
- 7.5.2 Vitamins and Minerals: South & Central America Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. South & Central America Parenteral Nutrition Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: South & Central America Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Clinics
- 8.2.1 Overview
- 8.2.2 Clinics: South & Central America Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. South & Central America Parenteral Nutrition Market – South and Central America Analysis
9.1 Overview
9.2 South and Central America- 9.2.1 South & Central America Parenteral Nutrition Market Breakdown, by Key Country, 2023 and 2030 (%)
- 9.2.1.1 South & Central America Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 Brazil: South & Central America Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.1.1 Brazil: South & Central America Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.1.2 Brazil: South & Central America Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.2 Argentina: South & Central America Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.2.1 Argentina: South & Central America Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.2.2 Argentina: South & Central America Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.3 Rest of South and Central America : South & Central America Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.3.1 Rest of South and Central America : South & Central America Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.3.2 Rest of South and Central America : South & Central America Parenteral Nutrition Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 ICU Medical Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Grifols SA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Pfizer Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Otsuka Pharmaceuticals Co Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 B Braun SE
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fresenius Kabi AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Aculife Healthcare Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Vifor Pharma Management AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full S Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.